Navigation Links
Charles Drew University researcher will be honored for discoveries

Dr. Mamdooh Ghoneum today will discuss his findings on cancer research and treatment at the Egyptian Embassy in Washington, D.C.

The event, sponsored by the Egyptian Cultural and Educational Bureau, will run from 6 p.m. to 8 p.m., followed by a reception.

Ghoneum, an Egyptian-born researcher and professor at Charles Drew University of Medicine and Science in Los Angeles, has been studying natural cures for cancer for more than two decades. His research has centered on a critical theory: That cancer cells, when exposed to small amounts of yeast, have died.

"I have no doubt that I am close to unlocking the mystery as to why cancer cells weaken to the point of destruction after eating common baker's yeast," Dr. Ghoneum said earlier this year. "The cells just gravitate to the yeast. I call it fatal attraction."

His recent experiments have shown that yeast created significant clearance when cancer cells metasized to lungs in mice. His research in previous years has shown that tumors in mice decreased in size when injected with yeast. Lately, Dr. Ghoneum has focused on figuring out how much yeast can be considered a safe and effective dosage.

His research has been reproduced by scientists worldwide, with results published in leading medical journals. The immunologist's research also has been affirmed at the U.S. Department of Health and Science, National Institute of Health.

Dr. Ghoneum earned his Ph.D at the University of Tokyo in 1980 and completed his postdoctoral studies at UCLA.

Reservations for today's event can be made at the embassy, located at 3521 International Court N.W. in Washington, by calling 202-296-3959 or by sending an email to


Contact: Daryl Strickland
Charles Drew University of Medicine and Science

Page: 1

Related biology news :

1. The surprising story of Charles Darwin and his homeopathic doctor
2. TSC honors Sen. Charles Schumer
3. GEN joins Charles Darwin 2009 celebration
4. Pest management specialist Charles Summers wins prestigious Woodworth Award
5. Why do we choose our mates? Ask Charles Darwin, prof says
6. 2009 Charles River Laboratories Excellence in Refinement Award
7. Charles Drew cancer studies with yeast yield excellent results
8. Charles Darwin really did have advanced ideas about the origin of life
9. Charles Darwin and modern biology
10. Charles Darwin: More than the origin
11. Charles Drew University, UC Irvine awarded $480,000 grant for research low birth weight infants
Post Your Comments:
(Date:11/11/2015)... 11, 2015   MedNet Solutions , an innovative SaaS-based ... research, is pleased to announce that it will be a ... event, to be held November 17-19 in ... live demonstrations of iMedNet , MedNet,s easy-to-use, ... iMedNet has been able to deliver time and cost ...
(Date:11/9/2015)... Nov. 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... announced broader entry into the automotive market with a ... the pace of consumer electronics human interface innovation. Synaptics, ... ideal for the automotive industry and will be implemented ... Europe , Japan , ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology: